This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to determine the affect of sedative practices in short-term patient outcome and long-term mental health. The majority of mechanically ventilated critical care patients experience anxiety, fear, discomfort, or frank pain. This may be caused by being in an unfamiliar environment, severe illness, prolonged immobility, sleep deprivation, delirium, or indwelling catheters. These feelings may lead to patient agitation and subsequent danger of self-extubation, removal of vital lines and tubes, and patient-ventilator complications. Some of these complications may lead to increased mortality while others may result in significant morbidity. Because of these concerns, there is a tendency to oversedate patients. Recently, certain methods of sedation have been associated with decreased time of mechanical ventilation and better overall outcomes. Research has shown that patients receiving continuous sedation had longer mechanical ventilation times and higher extubation failure rates compared to patients who received sedatives given by intermittent intravenous boluses. Another research group found that patients who are awoken once daily and asked to complete simple tasks such as hand grasping and following an observer with their eyes, also have shorter lengths of mechanical ventilation times. Although both of these methods have been shown to be superior to the traditional treatment, these two methods have not been compared to each other. In addition, delirium is a frequent occurrence in patients who are mechanically ventilated. The presence of delirium is associated with an increased risk for major complications such as cardiac arrest and longer length of stay in the intensive care unit. Therefore it is important to understand in impact of these two sedative regimens on the frequency of delirium. Patients who meet entry criteria and consent (or have a legal representative consent) to the study will be randomized to receive one of the two sedation methods. Patients in both groups will be evaluated twice daily whole intubated and on mechanical ventilation. Subsequently, both groups will be assessed prior to hospital discharge and at 6 months follow-up. Each patient will also receive a daily evaluation to determine level of sedation and agitation. Finally, blood samples will be taken for determination of the pharmacokinetics of sedative drugs. A second phase of the investigation will include the administration of quality of life and post-traumatic stress questionnaires to determine if one ventilation method is superior to the other in terms of overall mental health.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000065-44
Application #
7375131
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2005-12-01
Project End
2006-11-30
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
44
Fiscal Year
2006
Total Cost
$316
Indirect Cost
Name
Virginia Commonwealth University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Holkova, Beata; Yazbeck, Victor; Kmieciak, Maciej et al. (2017) A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Leuk Lymphoma 58:1349-1357
Corey, Kathleen E; Vuppalanchi, Raj; Vos, Miriam et al. (2015) Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 60:360-7
Eaton, J E; Juran, B D; Atkinson, E J et al. (2015) A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther 41:980-90
Worthington Jr, Everett L; Berry, Jack W; Hook, Joshua N et al. (2015) Forgiveness-reconciliation and communication-conflict-resolution interventions versus retested controls in early married couples. J Couns Psychol 62:14-27
Holkova, Beata; Kmieciak, Maciej; Perkins, E Brent et al. (2014) Phase I trial of bortezomib (PS-341; NSC 681239) and ""nonhybrid"" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms. Clin Cancer Res 20:5652-62
Lo, D J; Farris, A B; Song, M et al. (2013) Inhibition of ?v?6 promotes acute renal allograft rejection in nonhuman primates. Am J Transplant 13:3085-93
Jones, Robert; Vuky, Jacqueline; Elliott, Tony et al. (2013) Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer. Invest New Drugs 31:1001-7
Al Hawaj, M A; Martin, E J; Venitz, J et al. (2013) Monitoring rFVIII prophylaxis dosing using global haemostasis assays. Haemophilia 19:409-14
Noureddin, Mazen; Yates, Katherine P; Vaughn, Ivana A et al. (2013) Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 58:1644-54
Lo, D J; Anderson, D J; Weaver, T A et al. (2013) Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am J Transplant 13:320-8

Showing the most recent 10 out of 367 publications